Q3 2022 13F Holders as of 9/30/2022
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
227M
-
Number of holders
-
150
-
Total 13F shares, excl. options
-
85.2M
-
Shares change
-
+21.2M
-
Total reported value, excl. options
-
$1.02B
-
Value change
-
+$262M
-
Put/Call ratio
-
0.27
-
Number of buys
-
95
-
Number of sells
-
-46
-
Price
-
$11.98
Significant Holders of Gossamer Bio, Inc. - Common Stock (GOSS) as of Q3 2022
187 filings reported holding GOSS - Gossamer Bio, Inc. - Common Stock as of Q3 2022.
Gossamer Bio, Inc. - Common Stock (GOSS) has 150 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 85.2M shares
of 227M outstanding shares and own 37.47% of the company stock.
Largest 10 shareholders include HHLR ADVISORS, LTD. (7.42M shares), VANGUARD GROUP INC (7.35M shares), BlackRock Inc. (5.51M shares), EcoR1 Capital, LLC (4.16M shares), STATE STREET CORP (3.78M shares), BOXER CAPITAL, LLC (3.57M shares), NEA Management Company, LLC (3.47M shares), Artal Group S.A. (3.25M shares), Cormorant Asset Management, LP (3.2M shares), and Weiss Asset Management LP (2.77M shares).
This table shows the top 150 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.